04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1060 15 783 113 1376 188 1144
ERLYTX 81 0 0 2 24 6 37
GI 187 4 209 13 158 22 134
GU 411 2 104 22 268 40 244
LEUK 138 2 104 9 110 18 110
LUNG 178 2 104 15 183 32 195
LYMPH 396 6 313 30 365 49 298
MELAN 261 0 0 0 0 1 6
MMYEL 120 2 104 7 85 14 85
MULT 23 0 0 1 12 4 24
OTHER 41 1 52 5 61 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 2900 34 1773 217 2642 381 2320

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 123 2 104 19 231 31 189
ERLYTX 10 0 0 0 0 0 0
LEUK 636 9 470 56 682 97 590
LUNG 324 6 313 30 365 55 335
OTHER 36 0 0 1 12 4 24
PEOLC 124 0 0 1 12 10 61
PREV 224 6 313 28 341 48 292
SXQOL 567 11 574 48 584 79 481
Total 2044 34 1774 183 2227 324 1972

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 1060 15 783 113 1376 188 1144
CCD 123 2 104 19 231 31 189
ERLYTX 91 0 0 2 24 6 37
GI 187 4 209 13 158 22 134
GU 411 2 104 22 268 40 244
LEUK 774 11 574 65 791 115 700
LUNG 502 8 417 45 548 87 530
LYMPH 396 6 313 30 365 49 298
MELAN 261 0 0 0 0 1 6
MMYEL 120 2 104 7 85 14 85
MULT 23 0 0 1 12 4 24
OTHER 77 1 52 6 73 11 67
PEOLC 124 0 0 1 12 10 61
PREV 226 6 313 28 341 48 292
SXQOL 569 11 574 48 584 79 481
Total 4944 68 3547 400 4868 705 4292

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 685 10 522 88 1071 134 816
ERLYTX 44 0 0 1 12 3 18
GI 134 4 209 9 110 14 85
GU 345 2 104 19 231 36 219
LEUK 84 2 104 8 97 15 91
LUNG 114 2 104 10 122 20 122
LYMPH 256 4 209 18 219 31 189
MELAN 165 0 0 0 0 1 6
MMYEL 74 0 0 4 49 9 55
MULT 8 0 0 0 0 1 6
OTHER 41 1 52 5 61 7 43
PREV 2 0 0 0 0 0 0
SXQOL 2 0 0 0 0 0 0
Total 1954 25 1304 162 1972 271 1650

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
CCD 109 1 52 17 207 27 164
ERLYTX 10 0 0 0 0 0 0
LEUK 270 4 209 22 268 37 225
LUNG 202 3 157 12 146 31 189
OTHER 36 0 0 1 12 4 24
PEOLC 87 0 0 1 12 8 49
PREV 222 4 209 26 317 46 280
SXQOL 394 9 470 41 499 59 359
Total 1330 21 1097 120 1461 212 1290

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 878 14 730 110 1339 168 1023
CCD 145 1 52 21 256 29 177
ERLYTX 54 0 0 1 12 3 18
GI 137 2 104 8 97 13 79
GU 369 4 209 23 280 42 256
LEUK 354 6 313 30 365 52 317
LUNG 323 7 365 26 317 57 347
LYMPH 256 4 209 18 219 31 189
MELAN 165 0 0 0 0 1 6
MMYEL 65 0 0 4 49 9 55
MULT 27 0 0 3 37 6 37
OTHER 247 1 52 15 183 29 177
PEOLC 90 0 0 3 37 9 55
PREV 224 4 209 26 317 46 280
SXQOL 396 9 470 41 499 59 359
Total 3730 52 2713 329 4007 554 3375

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 873 15 783 82 998 137 834
ERLYTX 77 0 0 2 24 6 37
GI 109 1 52 7 85 12 73
GU 247 0 0 13 158 30 183
LEUK 104 0 0 4 49 8 49
LUNG 141 2 104 12 146 26 158
LYMPH 322 4 209 24 292 41 250
MMYEL 107 2 104 5 61 12 73
MULT 23 0 0 1 12 4 24
Total 2003 24 1252 150 1825 276 1681

04-FEB-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1918 27 1409 157 1911 278 1692
AFFIL 142 4 209 19 231 36 219
CCOP/NCORP 1224 15 783 106 1291 169 1029
Non-SWOG 1657 19 991 115 1400 219 1333
Total 4941 65 3392 397 4833 702 4273

04-FEB-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
ERLYTX SN2426 cSCC, IC Met/Inop, Amivantamab v Cetuximab 1 Y 28-JAN-26

04-FEB-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU S2210 Pros, High Risk, BRCA, Neoadj Carbo 1 T 21-JAN-26
GU S2200 pRCC, Adv, Cabo ± Atezo 1 T 16-JAN-26
MELAN EA6141 Melan, Adv, Nivolumab+Ipi ± Sargmostim 1 E 08-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 1 E 07-JAN-26
OTHER EA3161 HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo 2 E 07-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 0 E 05-JAN-26
GI A021806 Pancreas, Perioperative vs Adjuvant Chemo 1 E 05-JAN-26

04-FEB-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 10
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 9
LUNG LUNGMAP NSCLC, Adv, Master 1 6
PREV NRGCC005 Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs 1 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 2 5
LYMPH AHOD2131 cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy 2 3
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 3
LUNG S2409 ESCLC, Durvalumab +/- Biomarker Directed Tx 1 3